课题基金 / 基金详情

Somatostatin Receptor Subtype 5 Regulation of Islet Neoplasia

Somatostatin Receptor Subtype 5 Regulation of Islet Neoplasia
生长抑素受体亚型 5 对胰岛肿瘤的调节
批准号:
8627441
负责人:
FRANCIS CHARLES BRUNICARDI
金额:
$1.2万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2013-08-31

项目摘要

项目成果

FRANCIS CHARLES BRUNICARDI的其他基金

相似基金

相关文献

中文摘要
翻译
摘要:在当前的R-01资助期间,我们的团队取得了4项与人类和动物相关的发现
英文摘要
ABSTRACT: During the funding of the current R-01, our team made 4 discoveries related to human and mouse somatostatin receptor subtype five (hSSTR5, mSSTR5) and pancreatic duodenal homeobox-1 (PDX-1) that are highly translatable for patients suffering with islet neoplasia (INeo): 1. our SSTR5-/- mice develop INeo associated with hyperinsulinemia, hypoglycemia and PDX-1 overexpression, suggesting mSSTR5 regulates both insulin secretion and INeo via PDX-1; 2. PDX-1 regulates INeo cell proliferation and iv PDX-1 shRNA therapy prevents hypoglycemic death in a metastatic insulinoma mouse model, suggesting PDX-1 is a molecular target for INeo; 3. we found a germline hSSTR5 SNP with a proline to leucine substitution at C terminal position 335 (hSSTR5 P335L) in ~50% of human INeo tumors. Preliminary in vitro data reveal that hSSTR5 P335L is hypofunctional resulting in PDX-1 overexpression and lack of response to SSTR5 analogue PRL-1980 in INeo cells, suggesting genomic hSSTR5 variation predicts response to therapy; 4. our rat insulin promoter-thymidine kinase (RIP-TK) vector, which is activated by PDX-1, and F18-FHBG prodrug can be used to image PDX-1 expression in INeo tumors in mice and could be used to track response to therapy. Hypotheses: a) hSSTR5 regulates insulin and INeo via PDX-1, b) hSSTR5 P335L is a hypofunctional receptor with altered PDX-1 regulation of INeo, and c) genomic variation of hSSTR5 and variations in expression of hSSTR5, hSSTR5 P335L and PDX-1 predict response to targeted therapies. Specific Aim 1: to determine whether a) distribution of hSSTR5 genomic variation in INeo patients can be validated using TaqMan Allelic Discrimination assay and b) variations in expression of hSSTR5, hSSTR5 P335L and/or PDX-1 of INeo specimens can be validated using QPCR, Western blot and Quantum Dot (Q Dot) deconvolution imaging and image analysis. Specific aim 2: to determine whether a) hSSTR5 regulates insulin and INeo cell proliferation via PDX-1, b) hSSTR5 P335L is a hypofunctional receptor with altered PDX-1 regulation of INeo, and c) hSSTR5 genomic variation and variations in hSSTR5, hSSTR5 P335L and PDX-1 expression levels predict response to SSTR5-specific analogue PRL-1980 vs PDX-1 shRNA therapies in i) βTC-6hSSTR5 SCID mouse model, ii) βTC-6hSSTR5 P335L SCID mouse model, iii) βTC-6SSTR5KD (Knock Down) SCID mouse model, iv) hSSTR5 knock-in mice, v) hSSTR5 P335L knock-in mice and vi) SSTR5-/- mice. Specific Aim 3: to determine whether a) imaging agents to detect PDX-1 expression using rat insulin promoter-thymidine kinase (RIP-TK) in INeo mouse models from aim 2 can be validated using 18F-FHBG for microPET imaging and/or dual labeled analogues for optical imaging and tomography, b) the response to targeted therapies can be studied using RIP-TK/ 18F-FHBG microPET imaging and is dependent upon PDX-1 expression levels and c) microPET PRL- 1980-Cu64 imaging can differentiate between SSTR5 positive and SSTR5 negative INeo tumors and will confirm the role of PDX-1 in therapeutic response in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Somatostatin Receptor Subtype 5 Regulation of Islet Neoplasia
  • 批准号:
    8038523
  • 项目类别:
  • 资助金额:
    $20.86万
  • 财政年份:
    2010
  • 负责人:
    FRANCIS CHARLES BRUNICARDI
  • 依托单位:
Molecular Surgeon Symposium on Pancreatic Cancer
  • 批准号:
    6670370
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2003
  • 负责人:
    FRANCIS CHARLES BRUNICARDI
  • 依托单位:
PDX-1 is a Therapeutic Target for Pancreatic Cancer
  • 批准号:
    7526489
  • 项目类别:
  • 资助金额:
    $27.48万
  • 财政年份:
    2002
  • 负责人:
    FRANCIS CHARLES BRUNICARDI
  • 依托单位:
Pancreatic Cancer Treatment Using Surgery & Gene Therapy
  • 批准号:
    6874950
  • 项目类别:
  • 资助金额:
    $26.79万
  • 财政年份:
    2002
  • 负责人:
    FRANCIS CHARLES BRUNICARDI
  • 依托单位:
国内基金
海外基金
Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
  • 批准号:
    82371007
  • 项目类别:
    面上项目
  • 资助金额:
    48万元
  • 批准年份:
    2023
  • 负责人:
    雷浪
  • 依托单位:
Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    傅强
  • 依托单位:
丹参酮ⅡA通过靶向TRAIL-receptor和ULBPs增强NK细胞抗非小细胞肺癌效应的作用及分子机制研究
  • 批准号:
    81903932
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2019
  • 负责人:
    龚陈媛
  • 依托单位:
白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究